-
-
Our Expertise
Transplant
Cancer Care
Brain & Spine Care
Heart Health
Bone Health
Dr. Poh Yih Jia
Rheumatologist
Key achievements
- Established the rheumatology obstetrics clinic at Singapore General Hospital (SGH) since 2015
- Lead for the gout clinic at SGH since 2020
- Expert panel for the Ministry of Health Agency for Care Effectiveness’ clinical guidance on gout, 2019 and 2023
- Lead for value-driven care for acute gout at SGH since 2021
- Lead for building improvement capability, clinical performance improvement committee, Division of Medicine, SingHealth since 2022
Experience
Dr Poh Yih Jia is a rheumatologist at Mount Elizabeth Novena Hospital, Singapore.
She has special interests in systemic lupus erythematosus (SLE), arthritis, and the management of pregnancy and flares in patients with autoimmune diseases.
Dr Poh was a senior consultant in the department of rheumatology and immunology at Singapore General Hospital (SGH). She completed her medical degree and specialist training in rheumatology in New Zealand and was subsequently conferred fellowship to the Royal Australasian College of Physicians. She was awarded the Health Manpower Development Plan scholarship to further subspecialise in the management of pregnancy and flares in patients with autoimmune diseases at the Louise Coote Lupus Unit, Guy’s and St Thomas’ Hospital, UK.
At SGH, she spearheaded the set-up of the rheumatology obstetrics clinic, which is a one-stop integrated rheumatology and obstetrics clinic that provides specialised care to pregnant women with autoimmune diseases. She also spearheaded the development of the gout clinic, which provides multi-disciplinary care for complex gout patients. In addition, she led the SLE clinic, a specialised service dedicated to the management of patients with complex SLE.
She led the value-driven care initiative for gout in SGH, which aims to optimise patient outcomes through the implementation of evidence-based practices and standardised quality care pathways. She also served as a member of the expert panel for the Ministry of Health Agency for Care Effectiveness’ clinical guidance on gout. She has been practising medicine for more than 20 years.
She was a member of the Asia Pacific Lupus Collaboration, which is an international network of clinicians and researchers working to improve outcomes for SLE patients. She also contributes to regional collaboration in lupus care as a member of the SLE special interest group for the Asia Pacific League of Associations for Rheumatology.
Dr Poh is a core faculty of the senior residency programme in rheumatology, adjunct assistant professor at the Duke-NUS Medical School, clinical assistant professor at the Yong Loo Lin School of Medicine and clinical teacher at the Lee Kong Chian School of Medicine.
She is involved in research, with interests including maternal and foetal outcomes in pregnancies of patients with autoimmune diseases, SLE and models of care designed to improve outcome of patients with gout.
Associated treatments
- Joint Aspiration
- Intrarticular Injection
Awards and honours
- 2025
Singapore Health Quality Service Award (Gold) - 2024
SingHealth Long Service Award - 2023
Service with a Heart Award - 2022
Singapore General Hospital Innovation and Quality Circle Assessment (Silver) - 2021
Singapore General Hospital Innovation and Quality Circle Assessment (Silver) - 2021
Best Quality Improvement Team Project Award SingHealth - 2019
Singapore General Hospital Innovation and Quality Circle Assessment (Gold) - 2019
Service with a Heart Award - 2018
Best Quality Improvement Team Project Award SingHealth - 2016
Singapore Health Quality Service Award (Gold) - 2014
Service with a Heart Award
Research & publications
Kandane-Rathnayake, R., Louthrenoo, W., Lau, C. S., Hamijoyo, L., Cho, J., Lateef, A., Luo, S. F., Wu, Y., Navarra, S., Zamora, L., Li, Z., Chen, Y., Oon, S., Chan, M., Sockalingam, S., Hao, Y., Zhang, Z., Bae, S., Kikuchi, J., . . . Morand, E. (2025). Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort. Arthritis Research & Therapy, 27(1).
Poh, Y. J., Alrashid, A., Sangle, S. R., Higgins, E., Benton, E., McGibbon, D., & D’Cruz, D. P. (2022). Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes. Lupus, 31(9), 1078–1083.
Poh, Y. J., Yii, I. Y. L., Goh, L. H., Li, H. H., Yang, L., Tan, H. K., Thumboo, J., & Tan, L. K. (2020). Maternal and fetal outcomes in systemic lupus erythematosus pregnancies. Annals of the Academy of Medicine Singapore, 49(12), 963–970.
Poh, Y. J., Baptista, B., & D’Cruz, D. P. (2017). Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration. Expert Review of Clinical Immunology, 13(10), 925–938.
Contact Our Call Centre
Clinic
Centre for Rheumatology & Arthritis
38 Irrawaddy Road #07-32
Mount Elizabeth Novena Specialist Centre
SG 329563
Mount Elizabeth Novena Specialist Centre
SG 329563
6970 0350
